Global AI Diagnostics Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI10245964

Publication Date:

October 8, 2024

Pages:

110

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global AI Diagnostics market size was valued at US$ million in 2023. With growing demand in downstream market, the AI Diagnostics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global AI Diagnostics market. AI Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of AI Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the AI Diagnostics market.
As a subfield in artificial intelligence, diagnosis is concerned with the development of algorithms and techniques that are able to determine whether the behaviour of a system is correct.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on AI Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the AI Diagnostics market. It may include historical data, market segmentation by Type (e.g., Hardware, Software), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the AI Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the AI Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the AI Diagnostics industry. This include advancements in AI Diagnostics technology, AI Diagnostics new entrants, AI Diagnostics new investment, and other innovations that are shaping the future of AI Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the AI Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for AI Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the AI Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting AI Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the AI Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the AI Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the AI Diagnostics market.
Market Segmentation:
AI Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Hardware
Software
Service
Segmentation by application
Hospitals
Research Laboratories
Contract Research Organizations
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Oxitone Medical Ltd
MC10, Inc
Medtronic
UE LifeSciences
Vital Connect
Biomeme
MidMark Corp
Bio SB
Cerora
CellScope
Digital Diagnostics
Siemens Healthineers
Nanox
Roche

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global AI Diagnostics Market Size 2019-2030
2.1.2 AI Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 AI Diagnostics Segment by Type
2.2.1 Hardware
2.2.2 Software
2.2.3 Service
2.3 AI Diagnostics Market Size by Type
2.3.1 AI Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global AI Diagnostics Market Size Market Share by Type (2019-2024)
2.4 AI Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Research Laboratories
2.4.3 Contract Research Organizations
2.4.4 Others
2.5 AI Diagnostics Market Size by Application
2.5.1 AI Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global AI Diagnostics Market Size Market Share by Application (2019-2024)
3 AI Diagnostics Market Size by Player
3.1 AI Diagnostics Market Size Market Share by Players
3.1.1 Global AI Diagnostics Revenue by Players (2019-2024)
3.1.2 Global AI Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global AI Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI Diagnostics by Regions
4.1 AI Diagnostics Market Size by Regions (2019-2024)
4.2 Americas AI Diagnostics Market Size Growth (2019-2024)
4.3 APAC AI Diagnostics Market Size Growth (2019-2024)
4.4 Europe AI Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa AI Diagnostics Market Size Growth (2019-2024)
5 Americas
5.1 Americas AI Diagnostics Market Size by Country (2019-2024)
5.2 Americas AI Diagnostics Market Size by Type (2019-2024)
5.3 Americas AI Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI Diagnostics Market Size by Region (2019-2024)
6.2 APAC AI Diagnostics Market Size by Type (2019-2024)
6.3 APAC AI Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AI Diagnostics by Country (2019-2024)
7.2 Europe AI Diagnostics Market Size by Type (2019-2024)
7.3 Europe AI Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AI Diagnostics by Region (2019-2024)
8.2 Middle East & Africa AI Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa AI Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global AI Diagnostics Market Forecast
10.1 Global AI Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global AI Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas AI Diagnostics Forecast
10.1.3 APAC AI Diagnostics Forecast
10.1.4 Europe AI Diagnostics Forecast
10.1.5 Middle East & Africa AI Diagnostics Forecast
10.2 Americas AI Diagnostics Forecast by Country (2025-2030)
10.2.1 United States AI Diagnostics Market Forecast
10.2.2 Canada AI Diagnostics Market Forecast
10.2.3 Mexico AI Diagnostics Market Forecast
10.2.4 Brazil AI Diagnostics Market Forecast
10.3 APAC AI Diagnostics Forecast by Region (2025-2030)
10.3.1 China AI Diagnostics Market Forecast
10.3.2 Japan AI Diagnostics Market Forecast
10.3.3 Korea AI Diagnostics Market Forecast
10.3.4 Southeast Asia AI Diagnostics Market Forecast
10.3.5 India AI Diagnostics Market Forecast
10.3.6 Australia AI Diagnostics Market Forecast
10.4 Europe AI Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany AI Diagnostics Market Forecast
10.4.2 France AI Diagnostics Market Forecast
10.4.3 UK AI Diagnostics Market Forecast
10.4.4 Italy AI Diagnostics Market Forecast
10.4.5 Russia AI Diagnostics Market Forecast
10.5 Middle East & Africa AI Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt AI Diagnostics Market Forecast
10.5.2 South Africa AI Diagnostics Market Forecast
10.5.3 Israel AI Diagnostics Market Forecast
10.5.4 Turkey AI Diagnostics Market Forecast
10.5.5 GCC Countries AI Diagnostics Market Forecast
10.6 Global AI Diagnostics Forecast by Type (2025-2030)
10.7 Global AI Diagnostics Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Oxitone Medical Ltd
11.1.1 Oxitone Medical Ltd Company Information
11.1.2 Oxitone Medical Ltd AI Diagnostics Product Offered
11.1.3 Oxitone Medical Ltd AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Oxitone Medical Ltd Main Business Overview
11.1.5 Oxitone Medical Ltd Latest Developments
11.2 MC10, Inc
11.2.1 MC10, Inc Company Information
11.2.2 MC10, Inc AI Diagnostics Product Offered
11.2.3 MC10, Inc AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 MC10, Inc Main Business Overview
11.2.5 MC10, Inc Latest Developments
11.3 Medtronic
11.3.1 Medtronic Company Information
11.3.2 Medtronic AI Diagnostics Product Offered
11.3.3 Medtronic AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Medtronic Main Business Overview
11.3.5 Medtronic Latest Developments
11.4 UE LifeSciences
11.4.1 UE LifeSciences Company Information
11.4.2 UE LifeSciences AI Diagnostics Product Offered
11.4.3 UE LifeSciences AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 UE LifeSciences Main Business Overview
11.4.5 UE LifeSciences Latest Developments
11.5 Vital Connect
11.5.1 Vital Connect Company Information
11.5.2 Vital Connect AI Diagnostics Product Offered
11.5.3 Vital Connect AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Vital Connect Main Business Overview
11.5.5 Vital Connect Latest Developments
11.6 Biomeme
11.6.1 Biomeme Company Information
11.6.2 Biomeme AI Diagnostics Product Offered
11.6.3 Biomeme AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Biomeme Main Business Overview
11.6.5 Biomeme Latest Developments
11.7 MidMark Corp
11.7.1 MidMark Corp Company Information
11.7.2 MidMark Corp AI Diagnostics Product Offered
11.7.3 MidMark Corp AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 MidMark Corp Main Business Overview
11.7.5 MidMark Corp Latest Developments
11.8 Bio SB
11.8.1 Bio SB Company Information
11.8.2 Bio SB AI Diagnostics Product Offered
11.8.3 Bio SB AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bio SB Main Business Overview
11.8.5 Bio SB Latest Developments
11.9 Cerora
11.9.1 Cerora Company Information
11.9.2 Cerora AI Diagnostics Product Offered
11.9.3 Cerora AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Cerora Main Business Overview
11.9.5 Cerora Latest Developments
11.10 CellScope
11.10.1 CellScope Company Information
11.10.2 CellScope AI Diagnostics Product Offered
11.10.3 CellScope AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 CellScope Main Business Overview
11.10.5 CellScope Latest Developments
11.11 Digital Diagnostics
11.11.1 Digital Diagnostics Company Information
11.11.2 Digital Diagnostics AI Diagnostics Product Offered
11.11.3 Digital Diagnostics AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Digital Diagnostics Main Business Overview
11.11.5 Digital Diagnostics Latest Developments
11.12 Siemens Healthineers
11.12.1 Siemens Healthineers Company Information
11.12.2 Siemens Healthineers AI Diagnostics Product Offered
11.12.3 Siemens Healthineers AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Siemens Healthineers Main Business Overview
11.12.5 Siemens Healthineers Latest Developments
11.13 Nanox
11.13.1 Nanox Company Information
11.13.2 Nanox AI Diagnostics Product Offered
11.13.3 Nanox AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Nanox Main Business Overview
11.13.5 Nanox Latest Developments
11.14 Roche
11.14.1 Roche Company Information
11.14.2 Roche AI Diagnostics Product Offered
11.14.3 Roche AI Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Roche Main Business Overview
11.14.5 Roche Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂